New Zealand patients are reporting widespread non-compliance with a law that took effect in February allowing 12-month prescription repeats for chronic conditions—a policy implementation failure that appears driven by perverse financial incentives in the healthcare system.
The law was meant to reduce administrative burden on both patients and doctors. Instead of requiring patients with stable, long-term conditions to return every three months for prescription renewals, doctors could issue year-long scripts, cutting down on appointments and paperwork.
But two months after the law came into effect, patients on Reddit and social media are reporting that their GPs are still issuing three-month repeats, often without explanation. The pattern is clear enough to suggest systemic non-compliance rather than isolated cases.
The reason appears simple: money. Every prescription repeat requires a new script, and every script comes with a fee—typically $18-25 per visit or phone consultation. For patients managing chronic conditions like diabetes, hypertension, or thyroid disorders, that's $72-100 per year in repeat prescription fees.
For GP practices operating on thin margins, those repeat fees add up. Multiply by hundreds of patients with chronic conditions, and you're looking at tens of thousands of dollars in revenue. Implementing the 12-month law means cutting that income by 75%.
Mate, this is the sort of policy implementation failure that drives people mad. Government passes a sensible law meant to reduce hassle and costs, and the system finds a way to ignore it because the incentives point the wrong way.
The irony is particularly sharp because GP practices have been complaining for years about being overwhelmed with demand. The same doctors who say they're drowning in appointments are declining to implement a reform that would reduce appointment load.
That's not hypocrisy—it's economics. GP funding in New Zealand is a perennial problem, with practices heavily dependent on patient fees to supplement government capitation payments. When you're operating close to the line financially, giving up repeat prescription revenue isn't easy, even if it would free up appointment slots.
The Ministry of Health has confirmed the law allows 12-month prescriptions for stable chronic conditions, but implementation is at GP discretion. There's no enforcement mechanism, no penalty for non-compliance, and apparently no monitoring of uptake.
That's a policy design flaw. Passing a law without implementation oversight or addressing the underlying financial incentives means you're hoping for voluntary compliance that works against providers' economic interests.
